EP Europace

1. Europace29 Apr 2025

   Dronedarone provides effective early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria

   Secondary analysisArrhythmias & EP

2. Europace18 Apr 2025

   Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study

   Cohort studyHeart failure

3. Europace10 Apr 2025

   Tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy

   Cohort studyHeart failure

4. Europace8 Apr 2025

   Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillation

   Cohort studyArrhythmias & EP

5. Europace1 Apr 2025

   The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

   Guideline or statementArrhythmias & EP

6. Europace31 Mar 2025

   HIgh Power short duration radiofrequency ablation or cryoballoon ablation for paroxysmal Atrial Fibrillation (HIPAF trial)

   Randomised controlled trialArrhythmias & EP

7. Europace31 Mar 2025

   Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society

   Guideline or statementValvular & structural

8. Europace31 Mar 2025

   PULSE survey: Population Survey on Knowledge, Gaps and Perception of Heart Rhythm disorders—an initiative of the Scientific Initiatives Committee of the European Heart Rhythm Association

   Cross-sectional studyArrhythmias & EP

9. Europace31 Mar 2025

   Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society

   Guideline or statementArrhythmias & EP

10. Europace31 Mar 2025

    State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology

    Guideline or statementArrhythmias & EP

11. Europace30 Mar 2025

    European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society

    Guideline or statementArrhythmias & EP

12. Europace30 Mar 2025

    Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

    Guideline or statementArrhythmias & EP

13. Europace28 Mar 2025

    Lifestyle and risk factor modification in atrial fibrillation: a European Heart Rhythm Association survey

    Cross-sectional studyArrhythmias & EP

14. Europace25 Mar 2025

    Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial

    Randomised controlled trialArrhythmias & EP

15. Europace25 Mar 2025

    Sensing and detection performance of the novel, small-diameter OmniaSecure defibrillation lead: in-depth analysis from the LEADR trial

    Secondary analysisArrhythmias & EP

16. Europace19 Mar 2025

    Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)

    Randomised controlled trialArrhythmias & EP

17. Europace19 Mar 2025

    Pathophysiological aspects of carotid sinus massage

    Cohort studyArrhythmias & EP

18. Europace19 Mar 2025

    Late arrhythmic burden in patients with left bundle branch block after TAVR with the Evolut valve

    Cohort studyValvular & structural

19. Europace18 Mar 2025

    Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED registry)

    Cohort studyHeart failure

20. Europace14 Mar 2025

    Baseline and 10-year change in the number of ideal cardiovascular health metrics and sudden cardiac death in the community

    Cohort studyArrhythmias & EP

21. Europace14 Mar 2025

    Clinical profile and outcomes among patients with cardiac implantable electronic device presenting as isolated pocket infection, pocket-related infective endocarditis, or lead-related infective endocarditis

    Cohort studyCardio-oncology & other

22. Europace14 Mar 2025

    Outcomes of ventricular tachycardia ablation facilitated by pre-procedural cardiac imaging-derived scar characterization: a prospective multi-centre international registry

    Cohort studyArrhythmias & EP

23. Europace12 Mar 2025

    Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association

    Guideline or statementArrhythmias & EP

24. Europace12 Mar 2025

    Identifying extra pulmonary vein targets for persistent atrial fibrillation ablation: bridging advanced and conventional mapping techniques

    Mechanistic studyArrhythmias & EP

25. Europace11 Mar 2025

    Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study

    Cohort studyCongenital

26. Europace6 Mar 2025

    Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study

    Cohort studyArrhythmias & EP

27. Europace3 Mar 2025

    Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing

    Cohort studyArrhythmias & EP

28. Europace28 Feb 2025

    Identification of a new genetic locus associated with atrial fibrillation in the Taiwanese population by genome-wide and transcriptome-wide association studies

    Case-control studyArrhythmias & EP

29. Europace24 Feb 2025

    Decreased METTL3 in atrial myocytes promotes atrial fibrillation

    Mechanistic studyArrhythmias & EP

30. Europace24 Feb 2025

    Evoked delayed potential ablation for post-myocardial infarction ventricular tachycardia: results from a large prospective multicentre study

    Cohort studyCoronary & ACS

31. Europace20 Feb 2025

    Left atrial intramyocardial fat at pulmonary vein reconnection sites during atrial fibrillation redo ablation

    Cohort studyArrhythmias & EP

32. Europace17 Feb 2025

    Persistent atrial fibrillation ablation: glimpsing the light ahead?

    Research articleArrhythmias & EP

33. Europace17 Feb 2025

    External validation of a machine learning-based classification algorithm for ambulatory heart rhythm diagnostics in pericardioversion atrial fibrillation patients using smartphone photoplethysmography: the SMARTBEATS-ALGO study

    Diagnostic or prognostic studyArrhythmias & EP

34. Europace17 Feb 2025

    Comparative analysis of anaesthesia modalities in pulmonary vein isolation: insights from a prospective multicentre registry

    Cohort studyArrhythmias & EP

35. Europace14 Feb 2025

    Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED)

    Cohort studyArrhythmias & EP

36. Europace14 Feb 2025

    Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046—a systematic analysis of the Global Burden of Disease Study 2021

    Cohort studyArrhythmias & EP

37. Europace11 Feb 2025

    SCN5A variant type-dependent risk prediction in Brugada syndrome

    Cohort studyArrhythmias & EP

38. Europace6 Feb 2025

    Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank

    Cohort studyArrhythmias & EP

39. Europace21 Jan 2025

    Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry

    Cohort studyArrhythmias & EP

40. Europace21 Jan 2025

    The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice

    Cohort studyArrhythmias & EP

All 488 Briefs in ExploreShowing Briefs 201–240 of 488, newest first